405 related articles for article (PubMed ID: 30143559)
21. Minimal change nephropathy and focal segmental glomerulosclerosis.
Mathieson PW
Semin Immunopathol; 2007 Nov; 29(4):415-26. PubMed ID: 17955243
[TBL] [Abstract][Full Text] [Related]
22. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
23. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
25. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
26. Thrombospondin 1 Deficiency Ameliorates the Development of Adriamycin-Induced Proteinuric Kidney Disease.
Maimaitiyiming H; Zhou Q; Wang S
PLoS One; 2016; 11(5):e0156144. PubMed ID: 27196103
[TBL] [Abstract][Full Text] [Related]
27. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
[TBL] [Abstract][Full Text] [Related]
28. Krüppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease.
Wang L; Lin W; Chen J
Int J Biol Sci; 2019; 15(9):1955-1961. PubMed ID: 31523196
[TBL] [Abstract][Full Text] [Related]
29. EP300/CBP is crucial for cAMP-PKA pathway to alleviate podocyte dedifferentiation via targeting Notch3 signaling.
Chang K; Xue R; Zhao M; Zhao Y; Yu W; Zhao Z; Liu X
Exp Cell Res; 2021 Oct; 407(2):112825. PubMed ID: 34506759
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
31. Krüppel-like factor 15 is a key suppressor of podocyte fibrosis under rotational force-driven pressure.
Yu MY; Kim JE; Lee S; Choi JW; Kim YC; Han SS; Lee H; Cha RH; Lee JP; Lee JW; Kim DK; Kim YS; Yang SH
Exp Cell Res; 2020 Jan; 386(1):111706. PubMed ID: 31697927
[TBL] [Abstract][Full Text] [Related]
32. Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
Embry AE; Liu Z; Henderson JM; Byfield FJ; Liu L; Yoon J; Wu Z; Cruz K; Moradi S; Gillombardo CB; Hussain RZ; Doelger R; Stuve O; Chang AN; Janmey PA; Bruggeman LA; Miller RT
J Am Soc Nephrol; 2018 May; 29(5):1501-1512. PubMed ID: 29572404
[No Abstract] [Full Text] [Related]
33. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
34. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
[TBL] [Abstract][Full Text] [Related]
35. Krüppel-like factor 6 regulates mitochondrial function in the kidney.
Mallipattu SK; Horne SJ; D'Agati V; Narla G; Liu R; Frohman MA; Dickman K; Chen EY; Ma'ayan A; Bialkowska AB; Ghaleb AM; Nandan MO; Jain MK; Daehn I; Chuang PY; Yang VW; He JC
J Clin Invest; 2015 Mar; 125(3):1347-61. PubMed ID: 25689250
[TBL] [Abstract][Full Text] [Related]
36. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
38. Role of smooth muscle protein SM22α in glomerular epithelial cell injury.
Marshall CB; Krofft RD; Blonski MJ; Kowalewska J; Logar CM; Pippin JW; Kim F; Feil R; Alpers CE; Shankland SJ
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F1026-42. PubMed ID: 21289056
[TBL] [Abstract][Full Text] [Related]
39. Role of the retinoic acid receptor-α in HIV-associated nephropathy.
Ratnam KK; Feng X; Chuang PY; Verma V; Lu TC; Wang J; Jin Y; Farias EF; Napoli JL; Chen N; Kaufman L; Takano T; D'Agati VD; Klotman PE; He JC
Kidney Int; 2011 Mar; 79(6):624-634. PubMed ID: 21150871
[TBL] [Abstract][Full Text] [Related]
40. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
